NOVAVAX2019 新冠肺炎疫苗的紧急使用授权 (EUA) for the prevention of 2019 coronavirus

Update: 30 October, 2023

Novavax2019 coronavirus vaccine is an unapproved vaccine that can prevent 2019 coronavirus. The vaccine has been authorized for emergency use by the US Food and Drug Administration (FDA) as a primary series for the prevention of 2019 coronavirus in individuals 12 years of age and older and as a first booster dose for individuals 18 years of age and older under an emergency use authorization.

---

File format: PDF

Size: -

MD5 Checksum: F4AAE1A8F49671B7DDDCA07FC5B5B29E

Publication date: 30 October, 2023

Downloads: -

PDF Link: NOVAVAX2019 新冠肺炎疫苗的紧急使用授权 (EUA) for the prevention of 2019 coronavirus PDF